ICD-10-CM Billable Code

Z92.21

Personal history of antineoplastic chemotherapy

Clinical Classification Guidelines

Medical Intelligence & Overview

The ICD-10 code Z92.21 refers to a patient's personal history of antineoplastic chemotherapy. This classification is used by healthcare providers to document and track individual medical histories related to cancer treatment. Having a history of chemotherapy is significant in understanding a patient's overall health profile, potential side effects, and future medical considerations. While it does not imply active cancer treatment at present, it provides essential context for ongoing medical care, surveillance, and management of health conditions that may be influenced by previous chemotherapy.

Causes & Symptoms

Clinical Causes: A diagnosis of cancer requiring treatment with chemotherapy drugs Prior medical recommendation for antineoplastic (cancer-fighting) treatment History of cancer remission after chemotherapy therapy Development of secondary health issues related to past chemotherapy treatments

Key Symptoms: Fatigue or exhaustion Persistent nausea or gastrointestinal disturbances Weakness or decreased stamina Possible neurological effects such as numbness or tingling Signs of immune system impact, like increased susceptibility to infections Potential signs of organ-specific damage depending on the chemotherapy agents used

Diagnostic & Treatment

Diagnosis Path: The presence of a personal history of antineoplastic chemotherapy is documented through detailed medical records, including treatment summaries and oncological reports. Healthcare providers confirm this history during patient interviews and by reviewing past treatments, medication lists, and medical documentation. No specific diagnostic tests are necessary solely to identify the history; it relies on comprehensive patient history documentation and record-keeping. This code is used for coding and billing purposes to reflect past cancer treatments and associated medical histories.

Treatment Protocols: As this ICD-10 code indicates a historical treatment rather than current therapy, specific treatments are not prescribed solely based on this code. Management strategies involve ongoing surveillance for late effects of chemotherapy, monitoring for any recurrence of cancer, and addressing any health issues related to previous treatments. Preventive care, lifestyle modifications, and regular medical evaluations are typical components of ongoing health management for patients with a history of antineoplastic chemotherapy.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is Z92.21 a billable ICD-10 code?
Yes, Z92.21 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report Z92.21?
Clinical documentation must specify the nature of Personal history of antineoplastic chemotherapy and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

antineoplastic chemotherapy